Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression
- PMID: 22393204
- PMCID: PMC3706194
- DOI: 10.1001/archgenpsychiatry.2011.2273
Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression
Abstract
Context: The endocannabinoid system has been implicated in stress adaptation and the regulation of mood in rodent studies, but few human association studies have examined these links and replications are limited.
Objectives: To examine whether a synonymous polymorphism, rs1049353, in exon 4 of the gene encoding the human endocannabinoid receptor (CNR1) moderates the effect of self-reported childhood physical abuse on lifetime anhedonia and depression and to replicate this interaction in an independent sample.
Design, setting, and participants: Genetic association study in 1041 young US women with replication in an independent Australian sample of 1428 heroin-dependent individuals as cases and 506 participants as neighborhood controls.
Main outcome measures: Self-reported anhedonia and depression (with anhedonia).
Results: In both samples, individuals who experienced childhood physical abuse were considerably more likely to report lifetime anhedonia. However, in those with 1 or more copies of the minor allele of rs1049353, this pathogenic effect of childhood physical abuse was attenuated. Thus, in participants reporting childhood physical abuse, although 57.1% of those homozygous for the major allele reported anhedonia, only 28.6% of those who were carriers of the minor allele reported it (P=.01). The rs1049353 polymorphism also buffered the effects of childhood physical abuse on major depressive disorder; however, this influence was largely attributable to anhedonic depression. These effects were also noted in an independent sample, in which minor allele carriers were at decreased risk for anhedonia even when exposed to physical abuse.
Conclusions: Consistent with preclinical findings, a synonymous CNR1 polymorphism, rs1049353, is linked to the effects of stress attributable to childhood physical abuse on anhedonia and anhedonic depression. This polymorphism reportedly resides in the neighborhood of an exon splice enhancer; hence, future studies should carefully examine its effect on expression and conformational variation in CNR1, particularly in relation to stress adaptation.
Figures
Similar articles
-
Cannabinoid Receptor 1 rs1049353 Variant, Childhood Abuse, and the Heterogeneity of PTSD Symptoms: Results From the National Health and Resilience in Veterans Study.Chronic Stress (Thousand Oaks). 2021 Apr 29;5:24705470211011075. doi: 10.1177/24705470211011075. eCollection 2021 Jan-Dec. Chronic Stress (Thousand Oaks). 2021. PMID: 33997583 Free PMC article.
-
Increased risk of major depression by childhood abuse is not modified by CNR1 genotype.Am J Med Genet B Neuropsychiatr Genet. 2013 Mar;162B(2):224-6. doi: 10.1002/ajmg.b.32124. Epub 2012 Dec 19. Am J Med Genet B Neuropsychiatr Genet. 2013. PMID: 23255320 Free PMC article. No abstract available.
-
The rs1049353 polymorphism in the CNR1 gene interacts with childhood abuse to predict posttraumatic threat symptoms.J Clin Psychiatry. 2015 Dec;76(12):e1622-3. doi: 10.4088/JCP.15l10084. J Clin Psychiatry. 2015. PMID: 26717543 Free PMC article. No abstract available.
-
CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis.Addict Biol. 2011 Jan;16(1):1-6. doi: 10.1111/j.1369-1600.2009.00198.x. Addict Biol. 2011. PMID: 20192949 Review.
-
[Childhood stress and depression].Nihon Shinkei Seishin Yakurigaku Zasshi. 2013 Jun;33(3):105-10. Nihon Shinkei Seishin Yakurigaku Zasshi. 2013. PMID: 25069243 Review. Japanese.
Cited by
-
Psychosocial factors and hematopoietic stem cell transplantation: potential biobehavioral pathways.Psychoneuroendocrinology. 2013 Nov;38(11):2383-93. doi: 10.1016/j.psyneuen.2013.06.016. Epub 2013 Jul 8. Psychoneuroendocrinology. 2013. PMID: 23845514 Free PMC article. Review.
-
Cannabidiol as a Treatment for Mood Disorders: A Systematic Review.Can J Psychiatry. 2020 Apr;65(4):213-227. doi: 10.1177/0706743719895195. Epub 2019 Dec 13. Can J Psychiatry. 2020. PMID: 31830820 Free PMC article.
-
Endocannabinoid signaling in the etiology and treatment of major depressive illness.Curr Pharm Des. 2014;20(23):3795-811. doi: 10.2174/13816128113196660735. Curr Pharm Des. 2014. PMID: 24180398 Free PMC article. Review.
-
Preliminary Evidence for Anhedonia as a Marker of Sexual Trauma in Female Adolescents.Adolesc Health Med Ther. 2021 Jun 14;12:67-75. doi: 10.2147/AHMT.S300150. eCollection 2021. Adolesc Health Med Ther. 2021. PMID: 34163277 Free PMC article.
-
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity.Int J Neuropsychopharmacol. 2015 Sep 5;19(3):pyv095. doi: 10.1093/ijnp/pyv095. Int J Neuropsychopharmacol. 2015. PMID: 26342110 Free PMC article. Review.
References
-
- Fawcett J, Clark DC, Scheftner WA, Gibbons RD. Assessing anhedonia in psychiatric patients. Arch Gen Psychiatry. 1983;40:79–84. - PubMed
-
- Nelson JC, Charney DS, Quinlan DM. Evaluation of the DSM-III criteria for melancholia. Arch Gen Psychiatry. 1981;38:555–559. - PubMed
-
- Rush AJ, Weissenburger JE. Melancholic symptom features and DSM-IV. Am J Psychiatry. 1994;151:489–498. - PubMed
-
- Moreau JL. Validation of an animal model of anhedonia, a major symptom of depression. Encephale. 1997;23:280–289. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- AA09022/AA/NIAAA NIH HHS/United States
- K05 AA017688/AA/NIAAA NIH HHS/United States
- K05 AA017242/AA/NIAAA NIH HHS/United States
- R01 AA007728/AA/NIAAA NIH HHS/United States
- R56 DA012854/DA/NIDA NIH HHS/United States
- DA017305/DA/NIDA NIH HHS/United States
- R01 DA018267/DA/NIDA NIH HHS/United States
- R01 DA012854/DA/NIDA NIH HHS/United States
- R01 DA017305/DA/NIDA NIH HHS/United States
- AA007231/AA/NIAAA NIH HHS/United States
- AA013526/AA/NIAAA NIH HHS/United States
- R01 AA013987/AA/NIAAA NIH HHS/United States
- P50 AA011998/AA/NIAAA NIH HHS/United States
- DA12854/DA/NIDA NIH HHS/United States
- R01 DA023668/DA/NIDA NIH HHS/United States
- R01 AA009022/AA/NIAAA NIH HHS/United States
- R37 AA007231/AA/NIAAA NIH HHS/United States
- AA19596/AA/NIAAA NIH HHS/United States
- AA07728/AA/NIAAA NIH HHS/United States
- T32 AA013526/AA/NIAAA NIH HHS/United States
- AA013987/AA/NIAAA NIH HHS/United States
- AA11998/AA/NIAAA NIH HHS/United States
- R03 DA025886/DA/NIDA NIH HHS/United States
- R01 AA007231/AA/NIAAA NIH HHS/United States
- R01 AA017915/AA/NIAAA NIH HHS/United States
- R37 AA007728/AA/NIAAA NIH HHS/United States
- DA18267/DA/NIDA NIH HHS/United States
- DA23668/DA/NIDA NIH HHS/United States
- F31 AA019596/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical